Research map: Immunosuppressive medication patterns in rheumatoid arthritis–associated interstitial lung disease by antifibrotic documentation status: A multicenter U.S. electronic health record study

Back to the article

Papers in this map

  1. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline · Ganesh Raghu · 2022 · 2852 citations · Cited by this paper
  2. Neuromuscular junction biomarker CAF22 predicts functional decline in patients with chronic obstructive pulmonary disease · 2026 · Related
  3. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases · Kevin R. Flaherty · 2019 · 2443 citations · Cited by this paper
  4. Adults with congenital lung malformations: A descriptive analysis of an underexplored population · 2026 · Related
  5. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based study · Tim Bongartz · 2010 · 882 citations · Cited by this paper
  6. Use of dual targeting during volume control ventilation is associated with increased delivery of non-lung-protective tidal volumes · 2026 · Related
  7. A global federated real-world data and analytics platform for research · Matvey B. Palchuk · 2023 · 829 citations · Cited by this paper
  8. Step-DAWN: an Italian algorithm proposed for the management of inhaled corticosteroids in severe asthma · 2026 · Related
  9. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease · Pierre‐Antoine Juge · 2018 · 522 citations · Cited by this paper
  10. Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience · 2026 · Related
  11. Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial · Toby M. Maher · 2022 · 292 citations · Cited by this paper
  12. Sex-based differences in long-term respiratory and pulmonary vascular outcomes after acute pulmonary embolism: A propensity-matched analysis of 795,338 patients · 2026 · Related
  13. Methotrexate and rheumatoid arthritis associated interstitial lung disease · Pierre‐Antoine Juge · 2020 · 243 citations · Cited by this paper
  14. Rheumatoid arthritis-associated interstitial lung disease: Pathogenesis, risk stratification, and management · 2026 · Related
  15. Validation of rheumatoid arthritis diagnoses in health care utilization data · Seoyoung C. Kim · 2011 · 235 citations · Cited by this paper
  16. Oxidative Stress–Driven Dysregulation of the MMP-2/TIMP-2 Axis in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Genetic Polymorphisms, and Therapeutic Implications · 2026 · Related
  17. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort Study · Jeffrey A. Sparks · 2019 · 234 citations · Cited by this paper
  18. Smoking cessation and depression risk in newly diagnosed COPD patients: A nationwide cohort study · 2026 · Related
  19. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study · Joshua J. Solomon · 2022 · 218 citations · Cited by this paper
  20. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases · Sindhu R. Johnson · 2024 · 192 citations · Cited by this paper
  21. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease · Mitsuhiro Akiyama · 2022 · 167 citations · Cited by this paper
  22. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease · Scott M. Matson · 2022 · 98 citations · Cited by this paper
  23. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Population‐Based Cohort · Bilal F. Samhouri · 2022 · 89 citations · Cited by this paper
  24. ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG) · Katerina M. Antoniou · 2025 · 82 citations · Cited by this paper
  25. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial · Eric L. Matteson · 2023 · 80 citations · Cited by this paper
  26. Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon? · Ying Huang · 2019 · 57 citations · Cited by this paper
  27. Use of ICD-10 diagnosis codes to identify seropositive and seronegative rheumatoid arthritis when lab results are not available · Jeffrey R. Curtis · 2020 · 45 citations · Cited by this paper
  28. Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease · Pierre‐Antoine Juge · 2023 · 42 citations · Cited by this paper
  29. Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis · Bryant R. England · 2019 · 39 citations · Cited by this paper
  30. Use of ultrasound to diagnose and monitor interstitial lung disease in rheumatic diseases · Esther F. Vicente‐Rabaneda · 2021 · 38 citations · Cited by this paper
  31. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis · Jorge Rojas‐Serrano · 2022 · 35 citations · Cited by this paper
  32. The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey · Joshua J. Solomon · 2021 · 23 citations · Cited by this paper
  33. Associations between shortened telomeres and rheumatoid arthritis-associated interstitial lung disease among U.S. Veterans · Jake G. Natalini · 2022 · 22 citations · Cited by this paper
  34. Advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease: a retrospective, active-comparator, new-user, cohort study · Bryant R. England · 2025 · 20 citations · Cited by this paper
  35. Validation of serostatus of rheumatoid arthritis using ICD ‐10 codes in administrative claims data · Hemin Lee · 2023 · 18 citations · Cited by this paper
  36. Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease · Maria Otaola · 2024 · 18 citations · Cited by this paper
  37. A Systematic Review of the Key Predictors of Progression and Mortality of Rheumatoid Arthritis-Associated Interstitial Lung Disease · Laura Groseanu · 2024 · 17 citations · Cited by this paper
  38. Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients · Belén Atienza‐Mateo · 2025 · 14 citations · Cited by this paper
  39. Efficacy and safety of biological drugs in interstitial lung disease associated with connective tissue diseases · Esther F. Vicente‐Rabaneda · 2021 · 11 citations · Cited by this paper

Source: OpenAlex (CC0)